Aarier Pharma Private Limited

Aarier Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2021PTC372597 Incorporated 01 December 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹4.85 Cr
▲ 109% YoY
Net profit · FY 2025
₹5.95 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹7.49 Lakh
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings

About Aarier Pharma Private Limited

Data last updated:

Aarier Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC372597. Its GSTIN is 27AAWCA1975B1ZG (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Samir Kirtikant Vora and Bhavya Vipul Shah.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1009 Gold Crest Business Center Lt Road Borivali West, Mumbai, Maharashtra, India – 400092.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.85 Cr, a growth of 109% compared to the previous year. For the same year it recorded a net profit of ₹5.95 Lakh (net margin 1.2%) and EBITDA of ₹7.49 Lakh (EBITDA margin 1.5%).

As per MCA filings, the company has open charges of ₹1.4 Cr on record.

Company Details of Aarier Pharma Private Limited
CIN U51909MH2021PTC372597
Registration Number 372597
Incorporation Date 01 December 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    1009 Gold Crest Business Center Lt Road Borivali West, Mumbai, Maharashtra, India – 400092
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Aarier Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Aarier Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Aarier Pharma Private Limited in one report.

Financials from FY 2022 Directors & ownership Charges & compliance

Business Activity of Aarier Pharma Private Limited

The main business activity of Aarier Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Aarier Pharma Private Limited FY 2025 filings available

Aarier Pharma Private Limited reported revenue of ₹4.85 Cr (up 109% YoY) for FY 2025.

Revenue · FY 2025
₹4.85 Cr ▲ 109%
Net profit · FY 2025
₹5.95 Lakh margin 1.2%
EBITDA · FY 2025
₹7.49 Lakh margin 1.5%

Compounded Annual Growth Rate (CAGR) of Aarier Pharma Private Limited

Revenue CAGR growth
1 year
▲ 109%
EBITDA CAGR growth
1 year
▲ 199%
3 years · compounded
▲ 202%

Revenue rose 109% in the latest year. EBITDA rose 199% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Aarier Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹7.49 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹5.95 Lakh••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Aarier Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.5%••••••••••••
Net Profit Margin1.2%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aarier Pharma are in the company report.

Premium access

Financial statements from FY 2022

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Aarier Pharma Private Limited

Aarier Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Caventis Pharma Private Limited₹4.88 Cr (FY 2024)••••••••-11.0%••••Delhi, India
JJJ Pharma Private Limited₹4.87 Cr (FY 2025)••••••••92.0%••••Indira Nagar, Uttar Pradesh, India
Bidwan Engicon Trade and Services Private Limited₹4.87 Cr (FY 2024)••••••••19.0%••••Bhubaneswar, Odisha, India
Mag Pharma Private Limited₹4.87 Cr (FY 2025)••••••••6.0%••••Delhi, India
Serai Pharma Healthcare Solutions Private Limited₹4.86 Cr (FY 2025)••••••••-49.0%••••Communication, Mumbai, Maharashtra, India
Aarier Pharma Private Limited this company₹4.85 Cr (FY 2025)••••••••109.0%••••Mumbai, Maharashtra, India
Exhar Formulations Private Limited₹4.84 Cr (FY 2020)••••••••21.0%••••New Delhi, Delhi, India
Universal Biotechnology Private Limited₹4.83 Cr (FY 2025)••••••••17.0%••••New Delhi, Delhi, India
Won Healthcare Private Limited₹4.83 Cr (FY 2025)••••••••24.0%••••Muzaffarnagar, Uttar Pradesh, India
Evans Healthcare India Private Limited₹4.82 Cr (FY 2025)••••••••3.0%••••New Delhi, Delhi, India
Nebula Life Science Private Limited₹4.82 Cr (FY 2025)••••••••19.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Aarier Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Aarier Pharma Private Limited

Aarier Pharma Private Limited is audited by KRUNAL MEHTA & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
KRUNAL MEHTA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Aarier Pharma Private Limited

Aarier Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Samir Kirtikant VoraDirector01 Dec 20214 Years 10 MonthsCurrent
Bhavya Vipul ShahDirector01 Dec 20214 Years 10 MonthsCurrent

Ownership and Shareholding of Aarier Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Aarier Pharma Private Limited

Open charges
₹1.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹1.40 Cr
Latest charge details
DateLenderAmountStatus
23 Dec 2025Hdfc Bank Limited₹1.4 CrOpen

Total charge records: 1 View all charges

MSME Payment Delays by Aarier Pharma Private Limited

Aarier Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 18 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Besi Drugs Pvt Ltd••••••••••••
Nebula Helathcare Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Aarier Pharma Private Limited

Aarier Pharma Private Limited has a workforce of 0 employees as of Apr 05, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Aarier Pharma Private Limited

Aarier Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Bhavya Vipul Shah was appointed as Director on 01 Dec 2021.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 140.00 Lakh with Charge ID 101226638 was registered on 23 Dec 2025.
AGM
Aarier Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aarier Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Bhavya Vipul Shah was appointed as Director.
Appointed
Samir Kirtikant Vora was appointed as Director.
Incorporation
01 Dec 2021
Aarier Pharma Private Limited was registered on 01 Dec 2021 with Roc Mumbai I & aged 4 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Aarier Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aarier Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Aarier Pharma Private Limited

Aarier Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAWCA1975B1ZGMaharashtraActive12 Dec 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aarier Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aarier Pharma Private Limited

Aarier Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2021 (5+ years old) and is registered under CIN U51909MH2021PTC372597.

Aarier Pharma reported revenue of ₹4.85 Cr for FY 2025 (up 109% YoY).

Aarier Pharma has 2 current directors:

Aarier Pharma reported a net profit of ₹5.95 Lakh (net margin 1.2%) and EBITDA of ₹7.49 Lakh (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.

The GSTIN of Aarier Pharma is 27AAWCA1975B1ZG, registered in Maharashtra.

The CIN (Corporate Identification Number) of Aarier Pharma is U51909MH2021PTC372597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aarier Pharma was incorporated on 01 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Aarier Pharma by revenue are Caventis Pharma Private Limited, JJJ Pharma Private Limited, Bidwan Engicon Trade and Services Private Limited, Mag Pharma Private Limited, Serai Pharma Healthcare Solutions Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Bhavya Vipul Shah was appointed as Director on 01 Dec 2021. Samir Kirtikant Vora was appointed as Director on 01 Dec 2021.

Aarier Pharma has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 18 overdue payments to 2 micro and small suppliers. The latest return was filed on 27 Apr 2024.

The registered office of Aarier Pharma is at 1009 Gold Crest Business Center Lt Road Borivali West, Mumbai, Maharashtra, India – 400092.

Aarier Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available